Large-scale testing (Phase 3)Active Not RecruitingNCT04934475What this trial is testingMInimal Residual Disease Adapted StrategyWho this might be right forMultiple Myeloma Intergroupe Francophone du Myelome 791
Testing effectiveness (Phase 2)Study completedNCT00003222What this trial is testingVaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) University of Virginia 40
Testing effectiveness (Phase 2)Looking for participantsNCT04003051What this trial is testingWeb-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping StrategiesWho this might be right forThroat Carcinoma M.D. Anderson Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT01576172What this trial is testingAbiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer AJCC v7 National Cancer Institute (NCI) 159
Testing effectiveness (Phase 2)Looking for participantsNCT06324357What this trial is testingBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadWho this might be right forMetastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more Boehringer Ingelheim 768
Large-scale testing (Phase 3)Not Yet RecruitingNCT07633873What this trial is testingSYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）Who this might be right forNon-Small Cell Lung Cancer CSPC Megalith Biopharmaceutical Co.,Ltd. 500
Testing effectiveness (Phase 2)UnknownNCT05163483What this trial is testingTucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric CancerWho this might be right forEsophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Ruihua Xu 87
Large-scale testing (Phase 3)Study completedNCT00006229What this trial is testingPaclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer NCIC Clinical Trials Group 774
Large-scale testing (Phase 3)Study completedNCT00032175What this trial is testingGemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Cancer Research UK 508
Testing effectiveness (Phase 2)UnknownNCT04124666What this trial is testingClinical Study of Granulocyte Infusion for Advanced CancerWho this might be right forAdvanced Cancer Shanghai East Hospital 100
Not applicableLooking for participantsNCT07111195What this trial is testingFeasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)Who this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Juan M Garcia-Gomez 140
Not applicableLooking for participantsNCT06215495What this trial is testingA Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical TrialWho this might be right forRadiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more Zhujiang Hospital 88
Large-scale testing (Phase 3)Study completedNCT00002456What this trial is testingGraft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma Fred Hutchinson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05334329What this trial is testingGenetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsWho this might be right forAdvanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma+8 more University of California, Irvine 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04117945What this trial is testingRegorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerWho this might be right forBRAF V600E NegativeKRAS Gene Mutation NegativeLocally Advanced Unresectable Colorectal Adenocarcinoma+10 more Academic and Community Cancer Research United 22
Testing effectiveness (Phase 2)WithdrawnNCT01055301What this trial is testingS0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple MyelomaPlasma Cell Myeloma SWOG Cancer Research Network
Not applicableEnded earlyNCT02483377What this trial is testingPatient Navigation and Tailored Treatment Planning in Latina Patients With Breast CancerWho this might be right forBreast Carcinoma University of Southern California 13
Testing effectiveness (Phase 2)UnknownNCT02928575What this trial is testingCombining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With GlioblastomaWho this might be right forGlioblastoma Multiforme Bassam Abdulkarim 45
Early research (Phase 1)Study completedNCT02171637What this trial is testingDose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid TumorsWho this might be right forNeoplasms Boehringer Ingelheim 38
Early research (Phase 1)Looking for participantsNCT07668557What this trial is testingAnti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) iCell Gene Therapeutics 18